gene

(redirected from BRCA1 gene)
Also found in: Dictionary, Medical, Encyclopedia.
Related to BRCA1 gene: BRCA2 gene, BRCA2
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for gene

References in periodicals archive ?
"Previous research has shown us that in cells the BRCA1 gene makes a protein that helps repair damage to broken DNA.
In the future, we could potentially identify patients that have increased levels of LYN or a BRCA1 gene mutation, and design their breast cancer therapy to suit their type of cancer.
All rearrangements in our study population were found in the BRCA1 gene. No BRCA2 rearrangements were found among the 1809 patients.
Hollywood star Angelina Jolie made headlines in 2013 when she had a preventive double mastectomy after finding out she'd inherited the faulty BRCA1 gene, and she chose to have her ovaries removed two years later.
Genistein is the predominant isoflavone found in soy and it may actually block DNA methylation, the silencing of the BRCA1 gene.
According to (http://people.com/bodies/christina-applegate-ovaries-fallopian-tubes-removed-brca/) People , Applegate has the BRCA1 gene mutation, which predisposes her to developing cancer.
Becky Measures, who had a mastectomy at Wythenshawe hospital 11 years ago after learning she carried the BRCA1 gene mutation, said: "When they find that they have the BRCA1/2 gene, many women fear that they have to take action immediately.
According to the research findings, the mutation is found in the BRCA2 gene, as opposed to other countries where most mutations are found in the BRCA1 gene.
DALLAS, Texas, January 24, 2017 -- Researchers here have found that the BRCA1 gene is required for the survival of blood forming stem cells, which could explain why patients with BRCA1 mutations do not have an elevated risk for leukemia.
1, 2, 12 exons) and 3' region (C terminal, 18, 19, 20, 21, 22 exons) of BRCA1 gene which comprised of 1812bp, 1128bp and 2024bp, respectively was also performed.
Women with BRCA1 gene mutation at higher risk of deadly uterine cancer.
It has been observed during this study that the loss of BRCA1 gene expression and up-regulation of the COX-2 gene may have a role in canine tumors.
Overall, four distinct deleterious mutations within the BRCA1 gene were identified in patients tested.
A similar situation occurred in Europe where Myriad Genetics held similar patents such as EP 705 903 entitled 'Mutations of the BRCA1 gene linked to a predisposition to breast cancer and ovarian cancer' and another patent EP 705 902 on a similar topic, granted in 2001.